These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25978964)

  • 1. Identification of indole inhibitors of human hematopoietic prostaglandin D2 synthase (hH-PGDS).
    Edfeldt F; Evenäs J; Lepistö M; Ward A; Petersen J; Wissler L; Rohman M; Sivars U; Svensson K; Perry M; Feierberg I; Zhou XH; Hansson T; Narjes F
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2496-500. PubMed ID: 25978964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters.
    Trujillo JI; Kiefer JR; Huang W; Day JE; Moon J; Jerome GM; Bono CP; Kornmeier CM; Williams ML; Kuhn C; Rennie GR; Wynn TA; Carron CP; Thorarensen A
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3795-9. PubMed ID: 22546671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a scintillation proximity binding assay for high-throughput screening of hematopoietic prostaglandin D2 synthase.
    Meleza C; Thomasson B; Ramachandran C; O'Neill JW; Michelsen K; Lo MC
    Anal Biochem; 2016 Oct; 511():17-23. PubMed ID: 27485270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M; Spadola L; Lundquist B; Hawtin P; Dahmén J; Groth-Clausen I; Nilsson E; Persdotter S; von Wachenfeldt K; Folmer RH; Edman K
    J Med Chem; 2008 Apr; 51(7):2178-86. PubMed ID: 18341273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase.
    Weber JE; Oakley AJ; Christ AN; Clark AG; Hayes JD; Hall R; Hume DA; Board PG; Smythe ML; Flanagan JU
    Eur J Med Chem; 2010 Feb; 45(2):447-54. PubMed ID: 19939518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of crystal water molecules in a high-affinity inhibitor and hematopoietic prostaglandin D synthase complex by interaction energy studies.
    Takaya D; Inaka K; Omura A; Takenuki K; Kawanishi M; Yabuki Y; Nakagawa Y; Tsuganezawa K; Ogawa N; Watanabe C; Honma T; Aritake K; Urade Y; Shirouzu M; Tanaka A
    Bioorg Med Chem; 2018 Sep; 26(16):4726-4734. PubMed ID: 30121213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors.
    Deaton DN; Do Y; Holt J; Jeune MR; Kramer HF; Larkin AL; Orband-Miller LA; Peckham GE; Poole C; Price DJ; Schaller LT; Shen Y; Shewchuk LM; Stewart EL; Stuart JD; Thomson SA; Ward P; Wilson JW; Xu T; Guss JH; Musetti C; Rendina AR; Affleck K; Anders D; Hancock AP; Hobbs H; Hodgson ST; Hutchinson J; Leveridge MV; Nicholls H; Smith IED; Somers DO; Sneddon HF; Uddin S; Cleasby A; Mortenson PN; Richardson C; Saxty G
    Bioorg Med Chem; 2019 Apr; 27(8):1456-1478. PubMed ID: 30858025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hematopoietic prostaglandin D synthase inhibitor complex structures.
    Kado Y; Aritake K; Uodome N; Okano Y; Okazaki N; Matsumura H; Urade Y; Inoue T
    J Biochem; 2012 Apr; 151(4):447-55. PubMed ID: 22418579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-quality crystals of human haematopoietic prostaglandin D synthase with novel inhibitors.
    Takahashi S; Tsurumura T; Aritake K; Furubayashi N; Sato M; Yamanaka M; Hirota E; Sano S; Kobayashi T; Tanaka T; Inaka K; Tanaka H; Urade Y
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Jul; 66(Pt 7):846-50. PubMed ID: 20606289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel amide and imidazole compounds as potent hematopoietic prostaglandin D
    Olson KL; Holt MC; Ciske FL; Kramer JB; Heiple PE; Collins ML; Johnson CM; Ho CS; Morano MI; Barrett SD
    Bioorg Med Chem Lett; 2021 Feb; 34():127759. PubMed ID: 33383152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase.
    Aritake K; Kado Y; Inoue T; Miyano M; Urade Y
    J Biol Chem; 2006 Jun; 281(22):15277-86. PubMed ID: 16547010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.
    Irikura D; Aritake K; Nagata N; Maruyama T; Shimamoto S; Urade Y
    J Biol Chem; 2009 Mar; 284(12):7623-30. PubMed ID: 19131342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure.
    Cadilla R; Deaton DN; Do Y; Elkins PA; Ennulat D; Guss JH; Holt J; Jeune MR; King AG; Klapwijk JC; Kramer HF; Kramer NJ; Laffan SB; Masuria PI; McDougal AV; Mortenson PN; Musetti C; Peckham GE; Pietrak BL; Poole C; Price DJ; Rendina AR; Sati G; Saxty G; Shearer BG; Shewchuk LM; Sneddon HF; Stewart EL; Stuart JD; Thomas DN; Thomson SA; Ward P; Wilson JW; Xu T; Youngman MA
    Bioorg Med Chem; 2020 Dec; 28(23):115791. PubMed ID: 33059303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new inhibitors for human hematopoietic prostaglandin D2 synthase among FDA-approved drugs and other compounds.
    Mazari AM; Hegazy UM; Mannervik B
    Chem Biol Interact; 2015 Mar; 229():91-9. PubMed ID: 25603235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematopoietic prostaglandin D synthase inhibitors for the treatment of duchenne muscular dystrophy].
    Kamauchi S; Urade Y
    Brain Nerve; 2011 Nov; 63(11):1261-9. PubMed ID: 22068479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet lysate suppresses the expression of lipocalin-type prostaglandin D2 synthase that positively controls adipogenic differentiation of human mesenchymal stromal cells.
    Lange C; Brunswig-Spickenheier B; Eissing L; Scheja L
    Exp Cell Res; 2012 Nov; 318(18):2284-96. PubMed ID: 22698646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors.
    Schulte CA; Deaton DN; Diaz E; Do Y; Gampe RT; Guss JH; Hancock AP; Hobbs H; Hodgson ST; Holt J; Jeune MR; Kahler KM; Kramer HF; Le J; Mortenson PN; Musetti C; Nolte RT; Orband-Miller LA; Peckham GE; Petrov KG; Pietrak BL; Poole C; Price DJ; Saxty G; Shillings A; Smalley TL; Somers DO; Stewart EL; Stuart JD; Thomson SA
    Bioorg Med Chem Lett; 2021 Sep; 47():128113. PubMed ID: 33991628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Haberl EM; Rossi A; Pergola C; Dehm F; Northoff H; Troschuetz R; Sautebin L; Werz O
    Bioorg Med Chem; 2009 Dec; 17(23):7924-32. PubMed ID: 19884011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic prostaglandin D synthase inhibitors.
    Thurairatnam S
    Prog Med Chem; 2012; 51():97-133. PubMed ID: 22520473
    [No Abstract]   [Full Text] [Related]  

  • 20. Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid.
    Lee K; Pham VC; Choi MJ; Kim KJ; Lee KT; Han SG; Yu YG; Lee JY
    Bioorg Med Chem Lett; 2013 Jan; 23(1):75-80. PubMed ID: 23218602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.